The 36-month beta value for BDSX is at 1.09. Analysts have varying views on the stock, with 5 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for BDSX is 74.02M, and currently, shorts hold a 1.22% of that float. The average trading volume for BDSX on January 09, 2025 was 417.93K shares.
BDSX) stock’s latest price update
Biodesix Inc (NASDAQ: BDSX)’s stock price has plunge by -0.67relation to previous closing price of 1.49. Nevertheless, the company has seen a -3.27% plunge in its stock price over the last five trading sessions. zacks.com reported 2025-01-08 that Biodesix announces positive study data for its Nodify CDT blood-based lung nodule test published in CHEST Pulmonary Journal.
BDSX’s Market Performance
Biodesix Inc (BDSX) has seen a -3.27% fall in stock performance for the week, with a 9.63% gain in the past month and a -11.90% plunge in the past quarter. The volatility ratio for the week is 5.16%, and the volatility levels for the past 30 days are at 6.87% for BDSX. The simple moving average for the past 20 days is 3.79% for BDSX’s stock, with a -3.66% simple moving average for the past 200 days.
Analysts’ Opinion of BDSX
Craig Hallum, on the other hand, stated in their research note that they expect to see BDSX reach a price target of $3. The rating they have provided for BDSX stocks is “Buy” according to the report published on July 26th, 2024.
TD Cowen gave a rating of “Buy” to BDSX, setting the target price at $2.80 in the report published on May 13th of the previous year.
BDSX Trading at 5.66% from the 50-Day Moving Average
After a stumble in the market that brought BDSX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -33.03% of loss for the given period.
Volatility was left at 6.87%, however, over the last 30 days, the volatility rate increased by 5.16%, as shares surge +8.82% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.76% lower at present.
During the last 5 trading sessions, BDSX fell by -3.27%, which changed the moving average for the period of 200-days by +7.25% in comparison to the 20-day moving average, which settled at $1.4260. In addition, Biodesix Inc saw -3.27% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BDSX starting from SCHULER JACK W, who purchase 100,000 shares at the price of $1.23 back on Nov 21 ’24. After this action, SCHULER JACK W now owns 31,194,935 shares of Biodesix Inc, valued at $122,840 using the latest closing price.
Kennedy Lawrence T. Jr, the Director of Biodesix Inc, purchase 35,000 shares at $1.16 during a trade that took place back on Nov 21 ’24, which means that Kennedy Lawrence T. Jr is holding 10,411,024 shares at $40,562 based on the most recent closing price.
Stock Fundamentals for BDSX
Current profitability levels for the company are sitting at:
- -0.53 for the present operating margin
- 0.78 for the gross margin
The net margin for Biodesix Inc stands at -0.67. The total capital return value is set at -0.38. Equity return is now at value -331.82, with -46.24 for asset returns.
Based on Biodesix Inc (BDSX), the company’s capital structure generated 0.57 points at debt to capital in total, while cash flow to debt ratio is standing at -1.52. The debt to equity ratio resting at 1.32. The interest coverage ratio of the stock is -3.91.
Currently, EBITDA for the company is -37.1 million with net debt to EBITDA at -1.03. When we switch over and look at the enterprise to sales, we see a ratio of 3.75. The receivables turnover for the company is 8.16for trailing twelve months and the total asset turnover is 0.64. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.40.
Conclusion
In conclusion, Biodesix Inc (BDSX) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
